SRTA: Strata Critical Medical Company Sales Revenue

The business model of Strata Critical Medical Inc (SRTA) is based on scaling intellectual property, where unit costs remain minimal following the R&D phase. The company's trading revenue trend confirms this efficiency, and the indicator is currently fixed at 0.28. Revenue is generated through emergency organ logistics for hospitals, while growing demand for advanced air mobility among high-net-worth individuals expands the client base.

Revenue and Sales Volume: Strata Critical Medical (SRTA) for 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Strata Medical (SRTA)

- current price and projected stock value:

Share Price Strata Critical Medical|SRTA - Consensus Target

- market capitalization information:

Market Value Strata Critical Medical Corp|SRTA - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Strata Critical Medical|SRTA - Book Capitalization|Market-to-Book Ratio blade.com|SRTA - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

SRTA - Net Income|Expected Net Income Strata Critical Medical Inc|SRTA - P/E Multiple|Projected Price to Earnings Ratio Blade Air Mobility|SRTA - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple Strata Medical|SRTA - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Strata Critical Medical|SRTA - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months blade.com|SRTA - Earnings per share growth in current year|Net earnings per share change forecast for next year Strata Critical Medical Inc

- company sales and revenue statistics:

SRTA - Company Revenue|Company Future Sales Volume Strata Critical Medical Inc|SRTA - P/S Multiple|Market Cap to Future Revenue Ratio Strata Critical Medical Corp

Summary company analysis:SRTA Strata Critical Medical Inc

Product sample of Strata Critical Medical Corp

Screening for an asset's operational resilience is critical when constructing a long-term portfolio. This indicator measures daily cash inflows from the sale of goods and services, revealing the business's actual liquidity. For Strata Critical Medical (SRTA), this reflects the efficiency of aviation logistics contracts and express organ delivery partnerships. The trend of such inflows confirms the viability of the business model. By analyzing the company's commercial revenue, an investor can detect capital stagnation in a timely manner.

Key competitors